FDSVX
Price
$58.35
Change
+$0.44 (+0.76%)
Updated
May 8 closing price
Net Assets
5.52B
RGAGX
Price
$72.82
Change
+$0.54 (+0.75%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

FDSVX vs RGAGX

Header iconFDSVX vs RGAGX Comparison
Open Charts FDSVX vs RGAGXBanner chart's image
Fidelity Growth Discovery
Price$58.35
Change+$0.44 (+0.76%)
VolumeN/A
Net Assets5.52B
American Funds Growth Fund of Amer R6
Price$72.82
Change+$0.54 (+0.75%)
VolumeN/A
Net Assets283.8B
FDSVX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDSVX vs. RGAGX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDSVX is a Buy and RGAGX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 284B vs. FDSVX (5.52B). RGAGX pays higher dividends than FDSVX: RGAGX (0.70) vs FDSVX (0.00). FDSVX was incepted earlier than RGAGX: FDSVX (27 years) vs RGAGX (16 years). FDSVX (0.66) is less costly to investors than RGAGX (0.30). FDSVX is a more actively managed with annual turnover of: 41.00 vs. RGAGX (25.00). FDSVX has a lower initial minimum investment than RGAGX: FDSVX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 4.03 vs. FDSVX (-6.49). RGAGX return over 5 years is better than : 46.25 vs. FDSVX (42.58).
FDSVXRGAGXFDSVX / RGAGX
Total Expense Ratio0.660.30220%
Annual Report Gross Expense Ratio0.660.30220%
Fund Existence27 years16 years-
Gain YTD-6.051-2.321261%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.52B284B2%
Annual Yield % from dividends0.000.70-
Returns for 1 year-6.494.03-161%
Returns for 3 years33.6935.2296%
Returns for 5 years42.5846.2592%
Returns for 10 years134.8563.82211%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.450.34
+8.27%
ARKO Corp
VTRS9.090.49
+5.70%
Viatris
TCBI72.612.56
+3.65%
Texas Capital Bancshares
LRMR2.240.07
+3.23%
Larimar Therapeutics
CTXR0.70N/A
+0.29%
Citius Pharmaceuticals Inc